Report Company Directory

Luminex Corp

• Monthly LMI Update Independent Investment Research by Independent Investment Research
• Dropping Coverage by William Blair
• 2021 DC Day Review: Expect Incremental Policy Reform, Strong Support for Value-Based Care, Tech-Enabled Novel Delivery Models by William Blair
• Final Reminder: Virtual Washington, D.C. Day - This Wednesday, June 30, 2021 by William Blair
• Reminder: Virtual Washington, D.C. Day - June 30, 2021; Full Agenda Now Available by William Blair
• Register: Virtual Washington, D.C. Day - June 30, 2021 by William Blair
• Takeaways From Fireside Chats With 20 Life Sciences and 2 Med Tech Companies at the William Blair Growth Stock Conference by William Blair
• Save the Date - Washington, D.C. Day - June 30, 2021 by William Blair
• Takeaways From Two COVID-19-Related Events From This Week by William Blair
• US Healthcare "UBS Evidence Lab inside: Survey Highlights COVID-19 Impact..." by UBS AG

LUMINEX LTD

LUMIR INC

LUMIRADX LTD

• LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th by GlobeNewsWire
• LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche by GlobeNewsWire
• LMDX | Dropping Coverage by Raymond James
• LMDX | Not the First Group Resignation for Co-Founding Trio; Easing the Path to Funding Resolution? by Raymond James
• LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal by GlobeNewsWire
• LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub by GlobeNewsWire
• LMDX | Not So Fun to Keep Talking Funding, but More Activity to Come by Raymond James
• LMDX | First Take: Revenues in Line but Margins Miss by Raymond James
• LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24 by GlobeNewsWire
• LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests by GlobeNewsWire

LUMOS DIAGNOSTICS HLDGS LTD

• Lumos Diagnostics Appoints Doug Ward as CEO by GlobeNewsWire
• Le GCC de Liverpool et l’organisation Community Pharmacy Liverpool lancent le service FebriDx® dans plus de 100 pharmacies locales by BusinessWire
• Liverpool CCG and Community Pharmacy Liverpool Launch FebriDx® Service at More Than 100 Community Pharmacies by BusinessWire
• Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada by BusinessWire
• Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually by BusinessWire
• Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser by BusinessWire
• Lumos Diagnostics FY21 Full Year Results by BusinessWire